Myelin heterogeneity for assessing normal appearing white matter myelin damage in multiple sclerosis

Poljanka Johnson1, Irene M Vavasour2,3, Biljana Jonoska Stojkova4

  • 1Department of Medicine (Neurology), University of British Columbia, Vancouver, British Columbia, Canada.

Abstract

Insights

Myelin heterogeneity index (MHI) in normal-appearing white matter (NAWM) effectively distinguishes multiple sclerosis (MS) from controls. Combining myelin water fraction (MWF) metrics offers a comprehensive assessment of MS-related brain abnormalities and disability.

Area of Science:

  • Neuroimaging
  • Biomarkers
  • Multiple Sclerosis Research

Background:

  • Conventional MRI lacks microstructural detail for MS progression.
  • Myelin damage in normal-appearing white matter (NAWM) significantly contributes to MS disability.
  • Myelin water fraction (MWF) quantifies myelin content and variability.

Purpose of the Study:

  • Compare mean MWF, standard deviation (SD), and myelin heterogeneity index (MHI) in differentiating MS from controls.
  • Assess associations of MWF metrics with physical and cognitive disability in MS.
  • Evaluate MHI as a composite metric for myelin content and variability.

Main Methods:

  • Acquired myelin water imaging data from 91 MS patients and 31 healthy controls (HC).
  • Compared segmented whole-brain NAWM and corpus callosum (CC) NAWM MWF metrics between groups.
  • Assessed associations of mean MWF, SD, and MHI with Expanded Disability Status Scale and Symbol Digit Modalities Test.

Main Results:

  • NAWM and CC MHI demonstrated high area under the curve (.78 and .84, respectively) in distinguishing MS from HC.
  • MHI showed superior performance in differentiating MS patients from controls compared to mean MWF or SD alone.

Conclusions:

  • Mean MWF, SD, and MHI offer complementary insights into NAWM abnormalities in MS.
  • Utilizing all three MWF metrics provides a more detailed interpretation of MS-related brain changes.
  • These metrics aid in understanding regional and global NAWM abnormalities and their link to clinical outcomes.